Most Awaited Q3 Sale is back. Upto 30% discount on every report.
Candidiasis Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 April 28
SKU : PH2665
180 pages
Report Summary
Table of Content
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
What is the Growth Rate of the Candidiasis Therapeutics Market?
Reach at a high CAGR of 5.3% during the forecast period (2023-2030).
What Companies Are Included in the Candidiasis Therapeutics Market?
Pacgen Biopharmaceuticals, Viamet Pharmaceuticals Holdings, LLC, Novabiotics Limited, Astellas Pharma Incorporation., Cidara Therapeutics Inc.
Which region controlled the global market during 2023-2030?
North American region Controls the Candidiasis Therapeutics Market during 2023-2030.
Which is the fastest-growing region in the Candidiasis Therapeutics Market?
Among all regions, Asia Pacific is the fastest-growing market share during the forecast period.
Related Reports
healthcare-itDigital Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 November 16
Starting from
$4350
pharmaceuticalsDrugs for Vulvovaginal Candidiasis Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 September 22
Starting from
$4350
pharmaceuticalsCutaneous And Systemic Leishmaniasis Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 22
Starting from
$4350
pharmaceuticalsAntifungal Drugs Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 04
Starting from
$4350
pharmaceuticalsMyelofibrosis Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 05
Starting from
$4350
pharmaceuticalsPompe Disease Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350